Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary.

Turner D, Griffiths AM, Wilson D, Mould DR, Baldassano RN, Russell RK, Dubinsky M, Heyman MB, de Ridder L, Hyams J, Martin de Carpi J, Conklin L, Faubion WA, Koletzko S, Bousvaros A, Ruemmele FM.

Gut. 2019 Apr 12. pii: gutjnl-2018-317987. doi: 10.1136/gutjnl-2018-317987. [Epub ahead of print]

PMID:
30979718
2.

Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network.

Turner D, Koletzko S, Griffiths AM, Hyams J, Dubinsky M, de Ridder L, Escher J, Lionetti P, Cucchiara S, Lentze MJ, Koletzko B, van Rheenen P, Russell RK, Mack D, Veereman G, Vermeire S, Ruemmele F.

J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):183-7. doi: 10.1097/MPG.0000000000001024.

PMID:
26545204
3.

Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.

Ruemmele FM, Hyams JS, Otley A, Griffiths A, Kolho KL, Dias JA, Levine A, Escher JC, Taminiau J, Veres G, Colombel JF, Vermeire S, Wilson DC, Turner D.

Gut. 2015 Mar;64(3):438-46. doi: 10.1136/gutjnl-2014-307008. Epub 2014 May 12.

PMID:
24821616
4.

Particularities of IBD trials in children.

Turner D.

Curr Pharm Des. 2019 Mar 7. doi: 10.2174/1381612825666190307125511. [Epub ahead of print]

PMID:
30848191
5.

ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.

Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho KL, Veres G, Russell RK, Paerregaard A, Buderus S, Greer ML, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC; European Society of Pediatric Gastroenterology, Hepatology, and Nutrition.

J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):795-806. doi: 10.1097/MPG.0000000000000239.

PMID:
24231644
6.

Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement.

Leung WK, Ng SC, Chow DK, Lao WC, Leung VK, Li MK, Hui YT, Ng SS, Hui AJ, Lai ST, Lam JT, Poon JT, Chan AO, Yuen H, Wu JC; Hong Kong IBD Society; Hong Kong IBD Society.

Hong Kong Med J. 2013 Feb;19(1):61-8.

7.

Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK.

J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):257-291. doi: 10.1097/MPG.0000000000002035.

PMID:
30044357
8.

Nutrition in Paediatric Inflammatory Bowel Disease: A Position Paper on Behalf of The Porto IBD Group of ESPGHAN.

Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, de Ridder L, Escher JC, Hojsak I, Kolaček S, Koletzko S, Levine A, Lionetti P, Martinelli M, Ruemmele F, Russell RK, Boneh RS, van Limbergen J, Veereman G, Staiano A.

J Pediatr Gastroenterol Nutr. 2018 Jan 29. doi: 10.1097/MPG.0000000000001896. [Epub ahead of print]

PMID:
29384890
9.

Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care- an Evidence-Based Guideline from ECCO and ESPGHAN.

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK.

J Pediatr Gastroenterol Nutr. 2018 May 30. doi: 10.1097/MPG.0000000000002035. [Epub ahead of print]

PMID:
29851766
10.

Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, de Ridder L, Escher JC, Hojsak I, Kolaček S, Koletzko S, Levine A, Lionetti P, Martinelli M, Ruemmele F, Russell RK, Boneh RS, van Limbergen J, Veereman G, Staiano A.

J Pediatr Gastroenterol Nutr. 2018 Apr;66(4):687-708. doi: 10.1097/MPG.0000000000001896.

PMID:
29570147
11.

Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos KH, Croft N, Navas-López VM, Wilson DC, Lawrence S, Russell RK.

J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):292-310. doi: 10.1097/MPG.0000000000002036.

PMID:
30044358
12.

Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.

Ma C, Panaccione R, Fedorak RN, Parker CE, Khanna R, Levesque BG, Sandborn WJ, Feagan BG, Jairath V.

BMJ Open. 2017 Jun 9;7(6):e016146. doi: 10.1136/bmjopen-2017-016146.

13.

[Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].

Martín de Carpi J, Vila V, Varea V.

An Pediatr (Barc). 2011 Oct;75(4):232-8. doi: 10.1016/j.anpedi.2011.03.011. Epub 2011 May 5. Spanish.

14.

Anti-TNF therapy for paediatric IBD: the Scottish national experience.

Cameron FL, Wilson ML, Basheer N, Jamison A, McGrogan P, Bisset WM, Gillett PM, Russell RK, Wilson DC.

Arch Dis Child. 2015 Apr;100(4):399-405. doi: 10.1136/archdischild-2013-305812. Epub 2015 Feb 12.

PMID:
25678594
15.

Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis; An Evidence-based Consensus Guideline from ECCO and ESPGHAN.

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos KH, Croft N, Navas-López VM, Wilson DC, Lawrence S, Russell RK.

J Pediatr Gastroenterol Nutr. 2018 May 30. doi: 10.1097/MPG.0000000000002036. [Epub ahead of print]

PMID:
29851767
16.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

17.

Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries.

Dalzell AM, Ba'Ath ME.

Paediatr Int Child Health. 2019 Feb;39(1):48-58. doi: 10.1080/20469047.2019.1575056.

PMID:
30900526
18.

Inflammatory Bowel Disease Incidence is on the Continuous Rise Among All Paediatric Patients Except for the Very Young: A Nationwide Registry-based Study on 28-Year Follow-up.

Virta LJ, Saarinen MM, Kolho KL.

J Crohns Colitis. 2017 Feb;11(2):150-156. doi: 10.1093/ecco-jcc/jjw148. Epub 2016 Aug 23.

PMID:
27555642
19.

Important issues in the justification of a control treatment in paediatric drug trials.

Kelly LE, Davies EH, Saint-Raymond A, Tomasi P, Offringa M.

Arch Dis Child. 2016 Oct;101(10):962-7. doi: 10.1136/archdischild-2016-310644. Epub 2016 Apr 6. Review.

PMID:
27052950

Supplemental Content

Support Center